These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10074787

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Molecular and cellular biology of vasopressin and oxytocin receptors and action in the kidney.
    Bichet DG.
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):46-53. PubMed ID: 7850411
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor.
    Jans DA, Pavo I, Fahrenholz F.
    FEBS Lett; 1993 Jan 04; 315(2):134-8. PubMed ID: 8380270
    [Abstract] [Full Text] [Related]

  • 26. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation.
    Berrada K, Plesnicher CL, Luo X, Thibonnier M.
    J Biol Chem; 2000 Sep 01; 275(35):27229-37. PubMed ID: 10858434
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. I8-arachnotocin-an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor.
    Duerrauer L, Muratspahić E, Gattringer J, Keov P, Mendel HC, Pfleger KDG, Muttenthaler M, Gruber CW.
    Sci Rep; 2019 Dec 17; 9(1):19295. PubMed ID: 31848378
    [Abstract] [Full Text] [Related]

  • 30. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
    Tahara A, Tsukada J, Tomura Y, Kusayama T, Wada K, Ishii N, Taniguchi N, Suzuki T, Yatsu T, Uchida W, Shibasaki M.
    Pharmacol Res; 2005 Mar 17; 51(3):275-81. PubMed ID: 15661579
    [Abstract] [Full Text] [Related]

  • 31. Genomic and non-genomic mechanisms of oxytocin receptor regulation.
    Zingg HH, Grazzini E, Breton C, Larcher A, Rozen F, Russo C, Guillon G, Mouillac B.
    Adv Exp Med Biol; 1998 Mar 17; 449():287-95. PubMed ID: 10026816
    [Abstract] [Full Text] [Related]

  • 32. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
    Yibchok-anun S, Hsu WH.
    Life Sci; 1998 Mar 17; 63(21):1871-8. PubMed ID: 9825765
    [Abstract] [Full Text] [Related]

  • 33. Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
    Holmes CL, Landry DW, Granton JT.
    Crit Care; 2003 Dec 17; 7(6):427-34. PubMed ID: 14624682
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurohypophysial receptor gene expression by thymic T cell subsets and thymic T cell lymphoma cell lines.
    Hansenne I, Rasier G, Charlet-Renard Ch, DeFresne MP, Greimers R, Breton C, Legros JJ, Geenen V, Martens H.
    Clin Dev Immunol; 2004 Mar 17; 11(1):45-51. PubMed ID: 15154611
    [Abstract] [Full Text] [Related]

  • 36. Systemic oxytocin and vasopressin excite gastrointestinal motility through oxytocin receptor in rabbits.
    Li L, Kong X, Liu H, Liu C.
    Neurogastroenterol Motil; 2007 Oct 17; 19(10):839-44. PubMed ID: 17883435
    [Abstract] [Full Text] [Related]

  • 37. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.
    Ventura MA, René P, de Keyzer Y, Bertagna X, Clauser E.
    J Mol Endocrinol; 1999 Jun 17; 22(3):251-60. PubMed ID: 10343284
    [Abstract] [Full Text] [Related]

  • 38. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
    Schlosser SF, Almeida OF, Patchev VK, Yassouridis A, Elands J.
    Endocrinology; 1994 Nov 17; 135(5):2058-63. PubMed ID: 7956927
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.
    Terrillon S, Cheng LL, Stoev S, Mouillac B, Barberis C, Manning M, Durroux T.
    J Med Chem; 2002 Jun 06; 45(12):2579-88. PubMed ID: 12036367
    [Abstract] [Full Text] [Related]

  • 40. Oxytocin stimulates the translocation of oxytocinase of human vascular endothelial cells via activation of oxytocin receptors.
    Nakamura H, Itakuara A, Okamura M, Ito M, Iwase A, Nakanishi Y, Okada M, Nagasaka T, Mizutani S.
    Endocrinology; 2000 Dec 06; 141(12):4481-5. PubMed ID: 11108258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.